Tenaya Therapeutics
TNYA
97 hedge funds and large institutions have $48.8M invested in Tenaya Therapeutics in 2025 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 18 closing their positions.
472% more call options, than puts
Call options by funds: $452K | Put options by funds: $79K
50% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 18
50% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 20
20.02% more ownership
Funds ownership: 21.2% → 41.22% (+20%)
7% more funds holding
Funds holding: 91 → 97 (+6)
12% less capital invested
Capital invested by funds: $55.6M → $48.8M (-$6.76M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$5.71M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$5.65M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$5.44M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.75M |
| 5 |
BGM
Burkehill Global Management
New York
|
+$2.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$973K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$755K |
| 3 |
DP
Diadema Partners
Morristown,
New Jersey
|
-$511K |
| 4 |
TOCUITCONY
Trustees of Columbia University in the City of New York
New York
|
-$473K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$354K |
TNYA Hedge Fund Activity: Q4 2025 in Review
97 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q4 2025, worth a combined $48.8M — down 12% from $55.6M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new TNYA positions and 18 closed out — a net gain of 9 holders — while 30 added to existing stakes and 20 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $5.71M. The largest seller was Aberdeen Group, exiting entirely with an estimated $973K sold.
- 97 institutional investors held Tenaya Therapeutics (TNYA) as of Q4 2025, up from 91 in Q3 2025.
- Funds reported $48.8M of Tenaya Therapeutics stock for Q4 2025, down 12% quarter-over-quarter.
- 27 funds opened new Tenaya Therapeutics positions in Q4 2025 and 18 closed out, a net change of +9 holders.
- The largest Tenaya Therapeutics buyer in Q4 2025 was Citadel Advisors, an estimated $5.71M added.
- The largest Tenaya Therapeutics seller in Q4 2025 was Aberdeen Group, an estimated $973K sold.
Based on aggregated 13F filings for Q4 2025.